EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Nov. 1, 2018--
Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, announced
today Teri Sides has joined Surmodics as Senior Vice President and Chief
Marketing Officer, effective November 1, 2018.
"I am thrilled to welcome Teri to our internal team. Teri has been an
important contributor to our business, product and clinical strategy
since 2011, including being a founding member of our SurVeil, Avess and
Sundance drug-coated balloon development programs," said Gary Maharaj,
President and Chief Executive Officer of Surmodics. "Her leadership and
strategic marketing expertise will be critical to drive our efforts in
developing differentiated products that deliver strong clinical and
economic benefits while improving patient outcomes."
Sides is an industry veteran, bringing over 27 years of medtech and
healthcare experience. Prior to joining Surmodics, Teri served as
Founder and Chief Executive Officer of Projectory, a consulting firm
that provides strategic marketing services to med tech clients, ranging
from start-ups to global businesses. Prior to Projectory, Sides was the
Vice President of Marketing and Product Development for Arizant, Inc.
Acting as the chief architect for product and market growth strategies,
Teri led development of industry-leading products, including the world’s
first patient warming gown. Sides holds an MBA from the University of
Minnesota'sCarlson School of Management. She has more than eight
patents granted and several pending.
"I look forward to joining the Surmodics team and leveraging our
combined expertise to develop a meaningfully differentiated product
pipeline," said Sides. "Surmodics has demonstrated a commitment to
innovation. Their talented development teams and key technology assets
combined with the strength of their customer and clinical relationships
enable the creation of highly innovative product solutions for vascular
disease and in-vitro diagnostics."
As CMO, Sides will be responsible for developing and driving strategic
growth initiatives and will be a member of the senior leadership team
reporting directly to Gary Maharaj, Chief Executive Officer.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for
intravascular medical devices and a leading provider of chemical
components for in vitro diagnostic (IVD) immunoassay tests and
microarrays. Surmodics is pursuing highly differentiated whole-product
solutions that are designed to address unmet clinical needs for its
medical device customers and engineered to the most demanding
requirements. This key growth strategy leverages the combination of the
Company’s expertise in proprietary surface technologies, along with
enhanced device design, development and manufacturing capabilities. The
Company mission remains to improve the detection and treatment of
disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more
information, visit www.surmodics.com.
The content of Surmodics’ website is not part of this press release or
part of any filings that the company makes with the SEC.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements. Statements that
are not historical or current facts are forward-looking statements.
Forward-looking statements involve inherent risks and uncertainties, and
important factors could cause actual results to differ materially from
those anticipated, including the factors identified under “Risk Factors”
in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year
ended September 30, 2017, and updated in our subsequent reports filed
with the SEC. These reports are available in the Investors section of
our website at www.surmodics.com
and at the SEC website at www.sec.gov.
Forward-looking statements speak only as of the date they are made, and
we undertake no obligation to update them in light of new information or
future events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005256/en/
Source: Surmodics, Inc.
Surmodics, Inc.
Tim Arens, 952-500-7000
ir@surmodics.com
